Preliminary Classification of Nonmalignant B Cell Proliferation in Sjögren's Syndrome: Perspectives on Pathobiology and Treatment Based on an Integrated Clinico-Pathologic and Molecular Study Approach

Author： de Vita S.   de Marchi G.   Sacco S.   Gremese E.   Fabris M.   Ferraccioli G.  

Publisher： Academic Press

ISSN： 1079-9796

Source： Blood Cells, Molecules, and Diseases, Vol.27, Iss.4, 2001-04, pp. : 757-766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Conspicuous Role For B Cells In Sjögren’s Syndrome

By  

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 3, 2007-06 ,pp. : 231-237

Humana Press, Inc

Access to resources Recommend Favorite

T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma

By Aki H.   Tuzuner N.   Ongoren S.   Baslar Z.   Soysal T.   Ferhanoglu B.   Sahinler I.   Aydin Y.   Ulku B.   Aktuglu G.  

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 229-236

Elsevier

Access to resources Recommend Favorite

The Future of Biologic Agents in the Treatment of Sjögren’s Syndrome

By  

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 3, 2007-06 ,pp. : 292-297

Humana Press, Inc

Access to resources Recommend Favorite

Use of Muscarinic Agonists in the Treatment of Sjögren's Syndrome

By Fox R.I.   Konttinen Y.   Fisher A.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 249-263

Academic Press

Access to resources Recommend Favorite

Molecular-Targeted and Cell-Based Therapies for Sjogren’s Syndrome

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite